Literature DB >> 19914670

Aspirin for the primary prevention of vascular events?

G Morgan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19914670     DOI： 10.1016/j.puhe.2009.10.007

Source DB:  PubMed          Journal:  Public Health        ISSN： 0033-3506            Impact factor:   2.427


× No keyword cloud information.
  7 in total

1.  [Acetylsalicylic acid protects against solid tumors].

Authors:  J R Izbicki; B T Hofmann; S Nitschmann
Journal:  Internist (Berl)       Date:  2012-02       Impact factor: 0.743

2.  Critical views in gastroenterology & hepatology: aspirin prophylaxis: putting gut bleeds into perspective.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-01

3.  Aspirin minimized the pro-metastasis effect of sorafenib and improved survival by up-regulating HTATIP2 in hepatocellular carcinoma.

Authors:  Lu Lu; Hui-Chuan Sun; Wei Zhang; Zong-Tao Chai; Xiao-Dong Zhu; Ling-Qun Kong; Wen-Quan Wang; Ke-Zhi Zhang; Yuan-Yuan Zhang; Qiang-Bo Zhang; Jian-Yang Ao; Jia-Qi Li; Lu Wang; Wei-Zhong Wu; Zhao-You Tang
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

4.  Aspirin for the older person: report of a meeting at the Royal Society of Medicine, London, 3rd November 2011.

Authors:  J Armitage; J Cuzick; P Elwood; M Longley; A Perkins; K Spencer; H Turner; S Porch; S Lyness; J Kennedy; Gn Henderson
Journal:  Ecancermedicalscience       Date:  2012-02-28

5.  Prophylactic Aspirin and Public.

Authors:  Gareth Morgan
Journal:  AIMS Public Health       Date:  2013-10-31

Review 6.  Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers.

Authors:  Peter C Elwood; Gareth Morgan; Christine Delon; Majd Protty; Julieta Galante; Janet Pickering; John Watkins; Alison Weightman; Delyth Morris
Journal:  Ecancermedicalscience       Date:  2021-07-02

Review 7.  Aspirin and cancer: biological mechanisms and clinical outcomes.

Authors:  Peter Elwood; Majd Protty; Gareth Morgan; Janet Pickering; Christine Delon; John Watkins
Journal:  Open Biol       Date:  2022-09-14       Impact factor: 7.124
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.